219 related articles for article (PubMed ID: 28244220)
1. Study of Structure-active Relationship for Inhibitors of HIV-1 Integrase LEDGF/p75 Interaction by Machine Learning Methods.
Li Y; Wu Y; Yan A
Mol Inform; 2017 Jul; 36(7):. PubMed ID: 28244220
[TBL] [Abstract][Full Text] [Related]
2. Quantitative Structure-Activity Relationship Study for HIV-1 LEDGF/p75 Inhibitors.
Li Y; Tian Y; Xi Y; Qin Z; Yan A
Curr Comput Aided Drug Des; 2020; 16(5):654-666. PubMed ID: 31538902
[TBL] [Abstract][Full Text] [Related]
3. Structural basis for the potent inhibition of the HIV integrase-LEDGF/p75 protein-protein interaction.
Ribone SR; Quevedo MA
J Mol Graph Model; 2017 Aug; 75():189-198. PubMed ID: 28582696
[TBL] [Abstract][Full Text] [Related]
4. Insights into the interactions between HIV-1 integrase and human LEDGF/p75 by molecular dynamics simulation and free energy calculation.
Zhao Y; Li W; Zeng J; Liu G; Tang Y
Proteins; 2008 Aug; 72(2):635-45. PubMed ID: 18247352
[TBL] [Abstract][Full Text] [Related]
5. Blocking the interaction between HIV-1 integrase and human LEDGF/p75: mutational studies, virtual screening and molecular dynamics simulations.
Reddy KK; Singh P; Singh SK
Mol Biosyst; 2014 Mar; 10(3):526-36. PubMed ID: 24389668
[TBL] [Abstract][Full Text] [Related]
6. Classification of active and weakly active ST inhibitors of HIV-1 integrase using a support vector machine.
Yan A; Xuan S; Hu X
Comb Chem High Throughput Screen; 2012 Dec; 15(10):792-805. PubMed ID: 22934952
[TBL] [Abstract][Full Text] [Related]
7. Identification of the LEDGF/p75 binding site in HIV-1 integrase.
Busschots K; Voet A; De Maeyer M; Rain JC; Emiliani S; Benarous R; Desender L; Debyser Z; Christ F
J Mol Biol; 2007 Feb; 365(5):1480-92. PubMed ID: 17137594
[TBL] [Abstract][Full Text] [Related]
8. Fragment hopping approach directed at design of HIV IN-LEDGF/p75 interaction inhibitors.
De Luca L; Ferro S; Morreale F; Christ F; Debyser Z; Chimirri A; Gitto R
J Enzyme Inhib Med Chem; 2013 Oct; 28(5):1002-9. PubMed ID: 22803661
[TBL] [Abstract][Full Text] [Related]
9. Pharmacophore-based discovery of small-molecule inhibitors of protein-protein interactions between HIV-1 integrase and cellular cofactor LEDGF/p75.
De Luca L; Barreca ML; Ferro S; Christ F; Iraci N; Gitto R; Monforte AM; Debyser Z; Chimirri A
ChemMedChem; 2009 Aug; 4(8):1311-6. PubMed ID: 19565598
[TBL] [Abstract][Full Text] [Related]
10. The selenium-containing drug ebselen potently disrupts LEDGF/p75-HIV-1 integrase interaction by targeting LEDGF/p75.
Zhang DW; Yan HL; Xu XS; Xu L; Yin ZH; Chang S; Luo H
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):906-912. PubMed ID: 32228103
[TBL] [Abstract][Full Text] [Related]
11. The LEDGF/p75 integrase interaction, a novel target for anti-HIV therapy.
Christ F; Debyser Z
Virology; 2013 Jan; 435(1):102-9. PubMed ID: 23217620
[TBL] [Abstract][Full Text] [Related]
12. Molecular modeling study on the allosteric inhibition mechanism of HIV-1 integrase by LEDGF/p75 binding site inhibitors.
Xue W; Liu H; Yao X
PLoS One; 2014; 9(3):e90799. PubMed ID: 24599328
[TBL] [Abstract][Full Text] [Related]
13. Quinoline-based Protein-protein Interaction Inhibitors of LEDGF/p75 and HIV Integrase: An In Silico Study.
Chhokar N; Kalra S; Chauhan M; Munshi A; Kumar R
Curr Top Med Chem; 2018; 18(32):2800-2815. PubMed ID: 30747071
[TBL] [Abstract][Full Text] [Related]
14. Effective prediction model and determination of binding residues influential for inhibitors targeting HIV-1 integrase-LEDGF/p75 interface by employing solvent accessible surface area energy as key determinant.
Thangsunan P; Wongsaipun S; Kittiwachana S; Suree N
J Biomol Struct Dyn; 2020 Feb; 38(2):460-473. PubMed ID: 30744499
[TBL] [Abstract][Full Text] [Related]
15. Computational studies of the interaction between the HIV-1 integrase tetramer and the cofactor LEDGF/p75: insights from molecular dynamics simulations and the informational spectrum method.
Tintori C; Veljkovic N; Veljkovic V; Botta M
Proteins; 2010 Dec; 78(16):3396-408. PubMed ID: 20878714
[TBL] [Abstract][Full Text] [Related]
16. Cyclic peptide inhibitors of HIV-1 integrase derived from the LEDGF/p75 protein.
Hayouka Z; Hurevich M; Levin A; Benyamini H; Iosub A; Maes M; Shalev DE; Loyter A; Gilon C; Friedler A
Bioorg Med Chem; 2010 Dec; 18(23):8388-95. PubMed ID: 20974536
[TBL] [Abstract][Full Text] [Related]
17. The evaluation of statins as potential inhibitors of the LEDGF/p75-HIV-1 integrase interaction.
Harrison AT; Kriel FH; Papathanasopoulos MA; Mosebi S; Abrahams S; Hewer R
Chem Biol Drug Des; 2015 Mar; 85(3):290-5. PubMed ID: 24954548
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a flavonoid library for inhibition of interaction of HIV-1 integrase with human LEDGF/p75 towards a structure-activity relationship.
Yin ZH; Yan HL; Pan Y; Zhang DW; Yan X
Ann Med; 2022 Dec; 54(1):1590-1600. PubMed ID: 35658757
[No Abstract] [Full Text] [Related]
19. Dual inhibition of HIV-1 replication by integrase-LEDGF allosteric inhibitors is predominant at the post-integration stage.
Le Rouzic E; Bonnard D; Chasset S; Bruneau JM; Chevreuil F; Le Strat F; Nguyen J; Beauvoir R; Amadori C; Brias J; Vomscheid S; Eiler S; Lévy N; Delelis O; Deprez E; Saïb A; Zamborlini A; Emiliani S; Ruff M; Ledoussal B; Moreau F; Benarous R
Retrovirology; 2013 Nov; 10():144. PubMed ID: 24261564
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory profile of a LEDGF/p75 peptide against HIV-1 integrase: insight into integrase-DNA complex formation and catalysis.
Al-Mawsawi LQ; Christ F; Dayam R; Debyser Z; Neamati N
FEBS Lett; 2008 Apr; 582(10):1425-30. PubMed ID: 18331842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]